MyHealthChecked Shares Rise as Boots Agrees to Stock Coronavirus Test Kits
April 06 2021 - 8:44AM
Dow Jones News
By Matteo Castia
Shares in MyHealthChecked PLC rose Tuesday after the healthcare
company said it has entered into an agreement with pharmacy group
Boots U.K. to launch a home-testing nasal swab test and PCR
laboratory testing service to detect the coronavirus.
The company said the kit allows customers to take a nasal swab
themselves at home and send samples by post to laboratories.
The tests will be available at Boots' stores and online and be
processed at a laboratory run by MyHealthChecked and molecular
diagnostics supplier Yourgene Health PLC, the company said. Results
are then provided within 24 to 48 hours via an online portal, it
said.
The deal has an initial term of 12 months and a one-month notice
period for termination thereafter.
Boots is owned by drug-store chain Walgreens Boots Alliance
Inc.
Meanwhile, MyHealthChecked entered into an agreement with
Yourgene to act as the company's exclusive external provider of
testing services.
The deal isn't for a fixed period but is subject to a six-month
notice clause, and entails a minimum testing volume of 200 tests a
week and 800 tests a calendar month for the first three months, the
company said.
MyHealthChecked shares at 1305 GMT were up 1.65 pence, or 34%,
at 6.45 pence.
Write to Matteo Castia at matteo.castia@dowjones.com
(END) Dow Jones Newswires
April 06, 2021 09:29 ET (13:29 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Myhealthchecked (LSE:MHC)
Historical Stock Chart
From Apr 2023 to Apr 2024